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Purpose: Defects in cytochrome P450 1B1 (CYP1B1) cause primary congenital glaucoma. However, defects in the gene
have also been reported in primary open-angle glaucoma (POAG). Since POAG is primarily a complex disease, we
examined the potential of coding single nucleotide polymorphisms (cSNPs) in the gene for association with the disease.
Methods: Five coding SNPs – c.514 C>G (Arg48Gly), c.727 G>T (Ala119Ser), c.1666 C>G (Leu432Val), c.1719 C>T
(Asp449Asp), and c.1730 A>G (Asn453Ser) – were genotyped in 264 unrelated POAG patients and 95 controls. In
addition, 542 normal individuals selected from various ethnic groups representing the Indian population were also
genotyped for these cSNPs. The patterns of linkage disequilibrium between the SNPs and haplotype variations for
comparison between POAG patients and controls as well as different ethnic groups of the Indian population were
determined using Haploview. Allelic variants of Leu432Val were cloned by site-directed mutagenesis of normal CYP1B1
cDNA, which were used for transfection of retinal pigment epithelium (RPE) cells. The generation of reactive oxygen
species (ROS) was quantified by measuring fluorescence emission by degradation of CM-H2DCFDA using a fluoremeter.
Results: The c.1666G allele of the Leu432Val in CYP1B1 showed a statistically significant higher representation among
POAG patients compared to controls (p=0.0001; Odds ratio=6.027; 95% CI: 3.863–9.401) suggesting it to be a potential
risk allele toward disease predisposition. Analysis of genotype frequencies of the polymorphism between the two groups
demonstrated GG as a potential risk genotype (p=0.0001; Odds ratio=15.505; 95% CI: 5.529–43.474) for the disease.
CYP1B1 Val432 was estimated to generate higher ROS in RPE cells compared to its allelic variant (Leu432; p=0.0245
for 15 min and p=0.0197 for 30 min). Comparison of haplotype diversities revealed CGGTA as the risk haplotype for the
disease (p=0.0001, by Fisher’s exact test).
Conclusions: We report CYP1B1 c.1666G (Val432) as a susceptible allele for POAG and CGGTA as the risk haplotype
for the disease. Higher ROS generation by Val432 in CYP1B1 might lead to apoptotic change that leads to glaucoma.
Remarkable variation of the cSNPs observed among ethnic groups of India could provide insight for future epidemiological
studies on POAG in these population groups.
Primary  open-angle  glaucoma  (POAG)  is  the  most
common  form  of  glaucoma.  Among  14  implicated
chromosomal  loci  (GLC1A  –  GLC1N)  [1-12],  three
underlying candidate genes have been identified – myocilin
(MYOC),optineurin (OPTN), and WD40-repeat 36 (WDR36)
[2,13,14]. Recent studies suggest that POAG is caused mainly
by  genetic  predisposition  and  interaction  with  other  risk
factors [15]. The study, which is based on published literature,
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estimated that 72% of all POAG cases represent the inherited
or familial form of the disease that does not show a clear
pattern of Mendelian inheritance.
Among  genes  implicated  to  have  a  potential  role  in
POAG causation, cytochrome P450 1B1 (CYP1B1) poses as
an interesting candidate for investigation. CYP1B1, a member
of the cytochrome p450 family of monooxygenases, is also
widely  known  for  its  role  in  steroid  metabolism  and
xenometabolic detoxification [16]. Defects in CYP1B1 cause
an autosomal recessive form of primary congenital glaucoma
(PCG) [17,18]. In addition, recent studies indicate the gene’s
role  in  anterior  segment  dysgenesis  like  Peters’  anomaly
[18]. The gene has been found to be involved in expediting
disease onset in a familial case of open-angle glaucoma when
present  alongside  a  heterozygous  mutation  in  MYOC.
Therefore, the gene acts as a modifier locus [19]. Moreover,
CYP1B1  has  recently  been  shown  to  have  primary
involvement in a familial case of juvenile onset POAG [20,
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84121], and missense mutations have been detected in sporadic
POAG cases that are absent in controls [21,22].
In  addition  to  the  reported  involvement  of  missense
mutations  in  CYP1B1  with  different  forms  of  glaucoma,
coding single nucleotide polymorphisms (cSNPs) within the
gene have been found to be associated with a predisposition
for  complex  diseases  like  different  types  of  cancer  (viz.,
breast, lung, prostate, and endometrial cancer) [23-25]. A
study performed on CYP1B1 SNPs in French POAG patients
has  reported  an  association  of  a  common  coding
polymorphism  (Asn453Ser)  with  glaucomatous  clinical
features such as optic disc cupping and visual field alteration
[26]. The present study investigates the role of coding SNPs
detected in CYP1B1 in the POAG patient pool from Eastern
India  for  their  association  as  risk  factors  toward  POAG
predisposition. This study also attempts to investigate the
effect  of  the  Leu432Val  polymorphism  in  CYP1B1  on  a
generation  of  superoxide  species  as  a  potential  cause  of
neurodegeneration in POAG.
METHODS
Selection of study subjects: A group of 264 Indian POAG
patients residing in West Bengal (Eastern India) and speaking
Bengali  were  recruited  from  the  Dristipradip  Eye  Clinic,
Kolkata, India regardless of their status of family history of
POAG.  Diagnoses  involved  clinical,  ocular,  and  systemic
examinations.  Intraocular  pressure  (IOP)  was  initially
measured by air puff non-contact tonometer. A Goldman 3-
mirror gonioscope (Ocular Instrument, Bellevue, WA)was
used to assess the angles of the anterior chamber and optic
disc. The optic disc was also evaluated with a +78D lens in
some patients. Automated threshold field analysis was done
using the Humphrey Field Analyzer II (Carl Zeiss, Dublin,
CA) or the Medmont M600 Automated Perimeter (Medmont,
Camberwell, Victoria, Australia). The retinal nerve fiber layer
(RNFL) was investigated by scanning laser polarimetry with
variable corneal compensation technique. For glaucoma cases
identified by ocular examinations mentioned above, IOP was
reassessed by Goldmann applanation tonometry (Haag-Streit
USA Inc., Mason, OH) followed by pachymetry.
An  increased  intraocular  pressure  above  21  mmHg,
significant  cupping  of  the  optic  disc  with  or  without
peripapillary changes, and the presence of an open angle of
the anterior chamber raised the suspicion of POAG, which
was confirmed by typical reproducible visual field changes in
an automated perimetry test. Individuals who had an IOP of
less than 21 mmHg but had cupping of the optic disc and visual
field changes characteristic of POAG were also included in
the study. Thus, the patient pool consisted of 37 juvenile onset
open-angle glaucoma cases (ages 10–35 years) and 227 adult
onset open-angle glaucoma cases. The age at diagnosis ranged
from  10  to  84  years  with  a  mean±standard  deviation  of
55.69±16.78 years. However, individuals with any history of
inflammation or ocular trauma (past and present) and ocular
hypertension  were  excluded  from  this  study.  Ninety-five
ethnically matched controls were also recruited in this study.
They were determined to be negative for POAG based on a
routine  eye  examination  for  glaucoma  including  direct
ophthalmoscopy, a thorough examination of the optic disc and
intraocular  tension,  gonioscopy,  automated  visual  field
analysis, and retinal nerve fiber layer (RNFL) analysis with
the help of scanning laser polarimetry (SLP) with variable
corneal compensation.
For study of the Leu432Val polymorphism in CYP1B1 in
the general Indian population as shown in Figure 1, the study
subjects  consisted  of  542  individuals  from  24  ethnic
subgroups (each consisting of 20–23 individuals; Table 1)
classified on the basis of four major linguistic groups (Indo-
European,  Austro-Asiatic,  Tibeto-Burman,  and  Dravidian)
that define genetic variation in the population based on studies
conducted  on  mitochondrial  [27]  and  autosomal  [28,29]
genes.
Collection of blood samples and genomic DNA preparation:
Ten milliliters of peripheral blood was collected with EDTA
from the POAG patients and normal individuals with their
written consent. For the study of intragenic SNPs in CYP1B1
in  different  linguistic  groups  of  the  Indian  subcontinent,
populations were identified and samples were collected with
Figure 1. Map of India showing the respective locations of the 24
ethnic  groups  representing  the  population  of  the  country.  These
ethnic groups are classified on the basis of four major linguistic
groups  (Indo-European,  Austro-Asiatic,  Tibeto-Burman,  and
Dravidian) that define genetic variation in the population based on
reported studies conducted on mitochondrial and autosomal genes.
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842the  help  of  trained  anthropologists,  social  workers,  and
community health workers. Endogamy of the populations was
established  by  gathering  extensive  information  about  the
marriage patterns from pedigrees and interview of family
members of the donor as well as published literature. It was
ensured that the individuals were unrelated at least to the first
cousin level, and attempts were made to collect blood samples
from both males and females in equal numbers.
Genomic DNA was prepared from fresh whole blood
using the conventional phenol chloroform method followed
by ethanol precipitation. Then, the DNA was dissolved in TE
(10 mM Tris-HCl, 0.1 mM EDTA, pH 8.0) [30]. The study
protocol adhered to the tenets of the Declaration of Helsinki
and was approved by the Institutional Review Board.
Polymerase  chain  reaction  and  DNA  sequencing:  A
polymerase chain reaction (PCR) was performed in a total
volume of 25 μl containing 50–100 ng genomic DNA to
amplify  CYP1B1  exons  and  adjoining  splice  junctions  as
described in reference [20]. The specific PCR products were
subjected to bidirectional sequencing using an ABI 3130XL
DNA sequencer (Applied Biosystems, Foster City, CA) with
dye  termination  chemistry  to  identify  any  alteration  of
sequence. The selected cSNPs in different linguistic groups
of the Indian population were identified using homogeneous
MassEXTEND (hME) assay, an effective genotyping method
TABLE 1. ETHNIC GROUPS REPRESENTING THE GENERAL INDIAN POPULATION.
     Number of
Ethnic groups           Linguistic affiliation             individuals Geographical region
IE-E-IP1 Indo-European 23 East
IE-E-LP2 Indo-European 23 East
IE-NE-IP1 Indo-European 23 North-east
IE-N-LP9 Indo-European 22 North
IE-N-LP1 Indo-European 22 North
IE-W-LP1 Indo-European 23 West
IE-W-LP2 Indo-European 23 West
IE-W-LP3 Indo-European 22 West
IE-N-LP5 Indo-European 22 North
IE-NE-LP1 Indo-European 23 North-east
IE-E-LP4 Indo-European 23 East
IE-W-LP4 Indo-European 23 West
IE-N-SP4 Indo-European 23 North
IE-N-IP2 Indo-European 23 North
DR-C-IP1 Dravidian 22 Central
DR-S-LP3 Dravidian 23 South
DR-S-IP4 Dravidian 23 South
DR-S-LP2 Dravidian 23 South
TB-N-IP1 Tibeto-Burman 23 North
TB-NE-LP1 Tibeto-Burman 22 North-east
TB-N-SP1 Tibeto-Burman 23 North
AA-C-IP5 Austro-Asiatic 20 Central
AA-E-IP3 Austro-Asiatic 22 East
OG-W-IP Austro-Asiatic 23 West
The ethnic groups are described in the first column by their
linguistic affiliation, geographical location, and population
size in abbreviated form as follows: Linguistic groups- IE,
Indo European; DR, Dravidian; TT, Tibeto Burmese; AA,
Austro Asiatic; and OG, Out Groups; Geographical locations-
C, Central; E, Eastern; N, North; NE, Northeastern; and S,
South; Population types- IP, Isolated Population; LP, Large
population; and SP, Small population.
run on the MassARRAY system, done using SEQUENOME
(San Diego, CA) as described in reference [31].
Bioinformatic  and  statistical  analysis:  Haplotypes  were
determined  for  comparison  between  patients  and  controls
using  Haploview  3.2  software.  Allele  frequencies  of  the
cSNPs were compared between patients and controls using the
χ2 test. A generation of reactive oxygen species (ROS) was
compared  between  the  CYP1B1  allelic  variants  using  the
unpaired Student’s t-test.
Site-directed mutagenesis: A CYP1B1 cDNA construct in the
pcDNA3 mammalian expression vector (kindly supplied by
Dr. Thomas H. Friedberg, University of Dundee, Dundee,
Scotland) was used to generate a clone having a C to G change
at the 1,666th nucleotide. The oligonucleotides used for this
purpose were 5′– GTC TGT GAA TCA TGA CCC AGT GAA
GTG GCC TAA CCC GGA G –3′ and 5′– CTC CGG GTT
AGG CCA CTT CAC TGG GTC ATG ATT CAC AGA CC
–3′.  Site-directed  mutagenesis  and  the  subsequent
transformation of the mutant clone were performed using the
QuikChange XL Site-Directed Mutagenesis Kit (Stratagene,
La  Jolla,  CA)  according  to  the  manufacturer’s  protocol.
Plasmid isolation was done for both the c.1666C and c.1666G
variants cloned in the pcDNA3 vector using a Qiagen plasmid
mini kit following the protocol provided by the manufacturer
(Qiagen, Hilden, Germany), and the generation of the mutant
clone was confirmed by sequencing the inserts within the
mutagenized  recombinant  clone.  The  insert  containing
CYP1B1 cDNA in both the original and mutant clones was
entirely sequenced. It was confirmed that both the sequences
were  identical  except  the  intended  mutagenized  base  (c.
1666C>G).
Mammalian cell culture and transfection: The human retinal
pigment epithelium cell line, RPE8319 (a kind gift from Dr.
Frans Cremers, University Medical Center, Nijmegen, the
Netherlands),  was  maintained,  and  transfections  were
performed  following  the  protocol  described  previously  in
reference [32]. Cells were harvested after 42 h of transfection
for the detection of reactive oxygen species (ROS).
Detection  and  comparison  of  the  generation  of  reactive
oxygen  species:  Cells  were  transfected  with  recombinant
CYP1B1 clones with either the Leu432 or Val432 variant.
Forty-two  hours  after  transfection,  cells  were  trypsinized,
washed with PBS, kept in DMEM containing 10% FBS for 1
h,  and  treated  with  17β-estradiol.  Approximately  equal
numbers of transfected, untransfected, and H2O2-treated cells
were  incubated  with  20  µM  5-(and-6)-chloromethyl-2'7'-
dichlorodihydrofluorescein  diacetate  acetyl  ester  (CM-
H2DCFDA) at 37 °C for 30 min. Fluorescence was measured
through  a  spectrofluorometer  by  using  507  nm  as  the
excitation  wavelength  and  530  nm  as  the  emission
wavelength.  Basal  fluorescence  was  subtracted  from  all
measurements.
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Analysis of the coding regions in 264 POAG patients led to
the identification of five coding polymorphisms, Arg48Gly,
Ala119Ser,  Leu432Val,  Asp449Asp,  and  Asn453Ser  in
addition to six mutations identified earlier in nine POAG
patients [20].
Linkage disequilibrium pattern between the coding single
nucleotide polymorphisms: Out of five cSNPs analyzed in
CYP1B1, Arg48Gly and Ala119Ser, as well as Leu432Val and
Asp449Asp were found to be in perfect linkage disequilibrium
(LD; r2 value 1), which was calculated using the Haploview
program  (Figure  2).  Hence,  three  out  of  the  five  cSNPs
(Arg48Gly, Leu432Val, and Asn453Ser) were selected for
further study among patients and controls.
Leu432Val  as  a  risk  factor  for  primary  open-angle
glaucoma  predisposition:  Comparison  of  the  allele
frequencies  of  the  three  aforementioned  cSNPs  among
patients  and  controls  revealed  biased  distribution  for  the
Leu432Val polymorphism with c.1666G (Val432) showing
significantly higher representation (p=0.0001) among POAG
patients (Table 2) than in control individuals. Our observation
suggests c.1666G (Val432) as the “risk allele” toward POAG
predisposition (Odds ratio=6.027; 95% CI: 3.863 – 9.401) and
GG as a “risk genotype” (p=0.0001; Odds ratio=15.505; 95%
CI: 5.529 – 43.474). A similar observation was made when
the sample pool was analyzed separately for normotensive and
hypertensive groups.
CYP1B1  coding  single  nucleotide  polymorphisms  in
different ethnic groups of the Indian population: Based on the
LD patterns of CYP1B1 cSNPs discussed earlier, allele and
genotype  frequencies  of  the  three  cSNPs  in
CYP1B1,Arg48Gly, Leu432Val, and Asn453Ser were studied
in 542 individuals representing 24 ethnic groups of the Indian
population.
Leu432Val  showed  variable  minor  allele  frequencies
across  different  ethnic  groups  (Figure  3).  However,  it  is
noteworthy that c.1666G (Val432) was found to be the major
allele in the OG-W-LP5 ethnic group like Yoruba (YRI) with
the highest frequency of the risk genotype (GG) among all the
population groups. Interestingly, OG-W-LP5 is regarded as
an out-group of African descent. Detailed epidemiological
information on the prevalence of glaucoma in different parts
of the country especially in the OG-W-LP5 population and the
Figure 2. Linkage disequilibrium (LD)
pattern  (r2)  of  the  five  coding  single
nucleotide polymorphisms in CYP1B1
in  primary  open-angle  glaucoma
patients and controls. The extent of LD
lowers  as  the  shading  gets  lighter
(calculated  with  Haploview  3.2  using
standard color schemes). It is to be noted
that the direction (5′ to 3′) of the cSNPs
in the top panel (cartoon of the gene) and
the  bottom  panel  (LD  pattern)  is
reversed.
TABLE 2. ALLELE FREQUENCIES OF THE CYP1B1 CSNPS IN PRIMARY OPEN-ANGLE GLAUCOMA PATIENTS AND CONTROLS.
Sample
R48G (C>G) L432V (C>G) N453S (A>G)
Total
 C                G                      (chromosomes)
Total
C                 G                       (chromosomes)  
Total
A               G                    (chromosomes)
Case 0.68   0.32
(358)          (170)
528 0.51    0.49
(270)          (258)
528 0.87            0.13
(461)           (67)
528
Control 0.640          0.36
(122)          (68)
190 0.86             0.14
(164)           (26)
190 0.89            0.11
(170)           (20)
190
Comparison of the allele frequencies of the three cSNPs among cases (patients) and controls revealed biased distribution for
the Leu432Val polymorphism. c.1666G (Val432) showed significantly higher representation (p=0.0001) in POAG patients than
controls.
Molecular Vision 2008; 14:841-850 <http://www.molvis.org/molvis/v14/a100> © 2008 Molecular Vision
844correlation of disease prevalence with frequency of the c.
1666G  allele  in  the  CYP1B1  gene  can  shed  light  on  the
possible involvement of the variant in disease causation.
Functional  analysis  of  the  Leu432Val  variant  of
CYP1B1:  Leu432Val  is  reported  to  affect  the  catalytic
property of CYP1B1. Li et al. [33] reported that the Val432
form of CYP1B1 displayed a fourfold lower Km compared to
the Leu432 form. The metabolite, 4-hydroxyestradiol, is a
potent  carcinogen  resulting  from  17β-estradiol.  This
metabolite  is  known  to  undergo  redox  cycling  with  the
formation of reactive quinones, which can create oxidative
stress [34]. In the presence of estradiol, CYP1B1 having Val
at position 432 is expected to generate a higher amount of
reactive superoxides in cells compared to the enzyme having
Leu at position 432.
To  investigate  this,  retinal  pigment  epithelium  (RPE)
cells transfected with recombinant clones of CYP1B1 having
either the Val432 or Leu432 variant were treated with 17β-
estradiol  in  a  time-dependent  (15  and  30  min)  and  dose-
dependent  (400  and  600  nM)  manner  to  determine  the
optimum  conditions  (400  nM).  Cells  treated  with  25  µM
H2O2 were kept as a positive control (Figure 4) for the assay.
The fluorescence intensity estimates for cells transfected with
Leu432 or Val432 showed higher ROS generation (p=0.0245
for 15 min and p=0.0197 for 30 min) in cells transfected with
the Val432 variant at both time points (Figure 4).
Figure 3. Allele and genotype frequency
distribution  of  the  Leu432Val
polymorphism in CYP1B1 in different
ethnic  groups  of  Indian  and  HapMap
populations.  A:  Allele  frequency  of
various ethnic groups is shown by bar
diagram  while  the  overall  allele
frequency  among  Indians  as  well  as
populations included in HapMap project
are shown by pie chart. B: Similarly, all
three  genotype  frequencies  in  various
ethnic  groups  of  India  and  the
populations  included  in  HapMap  are
shown  by  bar  diagram  and  pie  chart,
respectively.  The  following  are  the
meanings of each abbreviation of the
linguistic  groups:  IE,  Indo  European;
DR,  Dravidian;  TT,  Tibeto  Burmese;
AA,  Austro  Asiatic;  OG,  Out  Group
population  types;  IP,  Isolated
Population; LP, Large population; and
SP, Small population. The following are
abbreviations  for  geographical
locations:  C,  Central;  E,  Eastern;  N,
North; NE, Northeastern; and S, South.
The following are the abbreviations for
HapMap  populations:  CEU,  CEPH
(Utah  residents  with  ancestry  from
northern  and  western  Europe);  CHB,
Han  Chinese  from  Beijing;  JPT,
Japanese  from  Tokyo;  YRI,  Yoruba
from Ibadan, Nigeria; and IND, Indian
population.
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845To further substantiate the generation of fluorescence due
to ROS, cells were incubated with 2 mM n-acetyl cysteine
(NAC),  which  is  known  to  scavenge  superoxides,  before
treatment with 17β-estradiol. The results showed a significant
decrease in fluorescence in NAC-treated cells compared to the
untreated ones (Figure 4), validating that the fluorescence
detected is due to the generation of superoxides. By DNA
sequencing, we ensured that the CYP1B1 cDNA insert in the
mutant clone (c.1666 G variant) did not harbor any other base
change that could have altered the biologic activity relative to
the wild type clone (c.1666 C variant).
CYP1B1 haplotype variation among primary open-angle
glaucoma patients and controls: Haplotypes were constructed
using Haploview with the studied cSNPs in the following
order: c.514 C>G, c.727 G>T, c.1666 C>G, c.1719 C>T, and
c.1730 A>G. Study of haplotype diversity (Figure 5) among
patients and controls revealed C-G-G-T-A as the predominant
haplotype  among  POAG  patients  (41%)  and  a  lower
representation among controls (10%; p=0.0001, by Fisher’s
exact  test;  Table  3).  Hence,  the  haplotype  represents  a
potential risk haplotype among POAG patients. Interestingly,
this haplotype has been reported to harbor a vast majority of
the CYP1B1 mutations causal to primary congenital glaucoma
(PCG) across different population groups worldwide [35].
Therefore, the risk haplotype for POAG as revealed by our
study also represents the risk haplotype for PCG. However,
among the nine POAG patients harboring CYP1B1 mutations
[20], we could determine haplotype in only two patients with
access to family members’ samples, but the risk haplotype (C-
G-G-T-A) was not identified in either of them. Incidentally,
we observed that the haplotype of the wild type CYP1B1
cDNA clone (c.1666 C variant), used to examine functional
variation of Leu432Val polymorphism, is the same as the most
common  haplotype  (C-G-C-C-A)  present  in  40%  of  the
controls examined (Table 3). The risk haplotype (C-G-G-T-
A),  which  is  overrepresented  in  the  POAG  patients,  is
functionally equivalent to the haplotype (C-G-G-C-A), which
is present in the mutant clone, since the cSNP (c.1719 C>T)
in LD with Leu432Val (c.1666 C>G) polymorphism codes for
a synonymous change (Asp449Asp).
TABLE 3. HAPLOTYPE DIVERSITY OF CYP1B1 CODING SINGLE NUCLEOTIDE POLYMORPHISMS
AMONG PRIMARY OPEN-ANGLE GLAUCOMA PATIENTS AND CONTROLS
SI number Haplotype POAG patients (%) Controls (%)
1 C-G-G-T-A 41 10
2 G-T-C-C-A 21.8 29.7
3 C-G-C-C-A 17.5 40
4 C-G-C-C-G 7.5 13.9
5 G-T-G-T-A 6.8 6.4
6 G-T-C-C-G 4.6 0
Haplotypes were constructed using cSNPs in the following
order: c.514 C>G, c.727 G>T, c.1666 C>G, c.1719 C>T, and
c.1730  A>G.  Among  major  haplotypes,  C-G-G-T-A  is
overrepresented  in  POAG  patients  (41%)  compared  to
controls (10%; p=0.0001, by Fisher’s exact test). Hence, C-
G-G-T-A represents a potential risk haplotype among POAG
patients.
Figure  4.  Comparison  of  reactive
oxygen  species  generation  in  retinal
pigment  epithelium  cells  transfected
with  CYP1B1  variants  of  Leu432Val
polymorphism.  A:  Cells  were
transfected with recombinant CYP1B1
clones with either the Leu432 or Val432
variant, trypsinized, washed with PBS,
and treated with 400 nM 17β-estradiol.
Approximately  equal  numbers  of
transfected,  untransfected,  and  H2O2-
treated cells (used as positive control)
were  incubated  with  CM-H2DCFDA
and  fluorescence  was  measured  as
described  in  Methods  section.  Basal
fluorescence  was  subtracted  from  all
measurements.  B:  To  substantiate  the
generation of fluorescence due to ROS,
cells subjected to similar treatment as
that of panel A were further treated with
or  without  2  mM  NAC  (n-acetyl
cysteine)  before  treatment  with  17β-
estradiol.  As  seen  in  the  figure  a
significant decrease in fluorescence in
NAC-treated  cells  were  observed
compared to the untreated ones.
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846Distribution of the risk haplotype throughout the Indian
population:  As  shown  in  Figure  5B,  the  study  on  the
distribution of the risk haplotype (C-G-G-T-A) in the various
ethnic groups of the Indian population revealed the highest
frequency  (26.6%)  among  the  ethnic  group,  IE-N-LP5,
followed by AA-C-IP5 (25%). In the OG-W-LP5 group where
c.1666G  (Val432)  is  the  major  allele,  the  risk  haplotype
frequency was estimated to be 16.7%.
DISCUSSION
POAG  is  primarily  a  complex  disease  showing  sporadic
occurrence  in  the  population  and  is  thought  to  involve
interplay between multiple genes and the environment. While
screening for mutations, we also detected SNPs in CYP1B1 of
POAG patients. SNPs play a major role in susceptibility to
complex diseases through their subtle effects on the protein.
A nonsynonymous SNP (Asn453Ser) in CYP1B1 has been
reported to be associated with clinical features like optic disc
cupping and visual field alteration in French POAG patients
[26].
The  significant  difference  reported  here  in  the
distribution of the allele frequency of the c.1666G (Val432)
allele of Leu432Val and corresponding GG genotype among
patients and controls points toward it being a risk allele for the
disease. Evidence from the literature indicates that the variant
has  been  implicated  in  head  and  neck  squamous  cell
carcinoma (HNSCC) where smokers with HNSCC having the
GG genotype are 20 times more likely to show p53 mutations
compared to individuals with the CC genotype [36]. Their data
indicates  a  strong  and  consistent  association  between  the
Leu432Val polymorphism in CYP1B1 and the smoke-induced
p53 mutations. The bias observed in the distribution of the
allele and genotype frequency of the Leu432Val prompted us
to look for variation in the haplotype diversities between the
two groups. Our initial observation that CGGTA serves as the
potential  risk  haplotype  for  POAG  has  been  recently
supported  by  another  study  [37]  and  represents  the  same
haplotype reported as a risk factor for PCG [35].
The reported effect of the Val432 variant in CYP1B1 on
higher enzyme activity [33] and the carcinogenic effects of
the downstream metabolite through quinone formation [34]
led us to explore the role of the variant on the generation of
superoxides.  Data  on  the  ROS  generation  in  RPE  cells
following  transfection  with  CYP1B1  variants  and  17β-
estradiol treatment shows a higher generation of ROS in cells
having  the  Val432  variant  in  the  CGGCA  haplotype
background  than  cells  having  the  Leu432  variant  in  the
CGCCA background. Therefore, it is likely that the mutant
CYP1B1  would  similarly  affect  trabecular  meshwork  and
retinal  ganglion  cells  involved  in  POAG  pathogenesis.
However, the observation needs to be confirmed in these cell
lines by replicating the same experiment or similar studies. It
is noteworthy that reactive superoxides generated in a non-
cycling cell population can lead to apoptosis, cell death, and
Figure  5.  CYP1B1  haplotype
distribution.  A:  CYP1B1  haplotype
variation  among  primary  open-angle
glaucoma  patients  and  controls  The
Study  of  haplotype  diversity  among
patients and controls revealed C-G-G-
T-A  as  the  predominant  haplotype
among  POAG  patients  (41%)  and  a
lower  representation  among  controls
(10%). Hence, the haplotype represents
a potential risk haplotype among POAG
patients. B: The distribution of the risk
haplotype (CGGTA) in 24 ethnic groups
of the Indian population. The study on
the distribution of the risk haplotype (C-
G-G-T-A) in the various ethnic groups
of  the  Indian  population  revealed  the
highest frequency (26.6%) among the
ethnic  group,  IE-N-LP5,  followed  by
AA-C-IP5  (25%).  In  the  OG-W-LP5
group where c.1666G (Val432) is the
major  allele,  the  risk  haplotype
frequency was estimated to be 16.7%.
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847degeneration  [38].  Hence,  such  generation  of  superoxides
over a long period of time can drive ocular cells to apoptosis,
and reports suggest oxidative stress to be one of the major
causes of apoptotic loss of retinal ganglion cells in glaucoma
[38].  Therefore,  inter-individual  differences  in  estrogen
metabolism resulting from the Leu432Val variant in CYP1B1
may lead to differences in individual susceptibility to complex
diseases  like  POAG.  In  a  reported  molecular  model  of
CYP1B1 [39], the 432nd residue is located in a large meander
region  structurally  close  to  Lys454.  The  latter  residue  is
structurally equivalent to Arg422 in CYP2B4, identified to be
involved  in  ionic  interactions  with  cytochrome  P450
reductase [33,40].
Comparison of the allele frequencies of the Leu432Val
polymorphism in the four world populations enlisted in the
HAPMAP database (Figure 3) showed Leu432 as the major
allele in Caucasians (CEU) and Asians (CHB and JPT) while
Val432 is the major allele among the Yuroba (YRI) from
Nigeria.  Interestingly,  epidemiological  studies  suggest  a
higher  incidence  of  glaucoma  among  Africans  and  Afro-
Americans compared to Caucasians [41,42]. Thus, it is worth
examining the association of the CYP1B1 variant with POAG
among  African  and/or  Afro-Americans  with  incidence  of
glaucoma similar to that performed in prostate cancer [43].
Allele  frequency  distribution  of  the  Leu432Val
polymorphism  across  different  subpopulations  showed
variable frequency of the minor allele with the risk allele being
the  major  allele  in  OG-W-LP5,  which  is  similar  to  that
observed in Yoruba.
The present study reports for the first time the association
of the Leu432Val polymorphism in CYP1B1 as a risk factor
for  POAG,  which  is  further  supported  by  the  in  vitro
functional analysis. Further, information gained on the genetic
variation of this polymorphism among different ethnic groups
of India could be helpful for future epidemiological studies on
the prevalence of POAG among Indian subpopulations. Such
effort  toward  disease  gene  exploration  has  been  recently
reported by Indian Genome Variation Consortium [44]. The
risk haplotype (CGGTA) represents one of the two ancestral
CYP1B1 haplotypes [35]. It would be interesting to study the
distribution  of  this  haplotype  with  the  simultaneous
assessment of its involvement in POAG predisposition in
different world populations.
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